摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(三氯甲基)苯甲酸 | 5264-40-4

中文名称
4-(三氯甲基)苯甲酸
中文别名
4-三氯甲基苯甲酸
英文名称
4-trichloromethyl-benzoic acid
英文别名
4-Trichlormethyl-benzoesaeure;41.41.41-Trichlor-p-toluylsaeure;4-Carboxy-benzotrichlorid;ω.ω.ω-Trichlor-p-tolylsaeure;p-(Trichloromethyl)benzoic-acid;p-Trichlormethylbenzoesaeure;4-(Trichloromethyl)benzoic acid
4-(三氯甲基)苯甲酸化学式
CAS
5264-40-4
化学式
C8H5Cl3O2
mdl
——
分子量
239.485
InChiKey
PGGOYACMHDPZQV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    193 °C
  • 沸点:
    345.6±42.0 °C(Predicted)
  • 密度:
    1.562±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2916399090

SDS

SDS:576e77bde3d33a3dcad8983fe564e6ab
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Cloning and Characterization of a Novel cDNA Sequence Encoding the Precursor of a Novel Venom Peptide (BmKbpp) Related to a Bradykinin-Potentiating Peptide from Chinese Scorpion Buthus martensii Karsch
    摘要:
    Based on the amino acid sequence of a bradykinin-potentiating peptide (Bpp) (peptide K-12) from scorpion Buthus occitanus, a full-length cDNA sequence encoding the precursor of a novel venom peptide (named BmKbpp) related to this Bpp, has been isolated and analyzed. The cDNA encodes a precursor of 72 amino acid residues, including a signal peptide of 22 residues and an extra Arg-Arg-Arg tail at the C-terminal end of the precursor which have to be removed in the processing step. The C-terminal region (21 residues) of the precursor is homologous (57% identical) with the sequence of peptide K-12, Thus, according to the primary structure of the BmKbpp precursor, there may be a propeptide between the signal peptide and the putative mature BmKbpp at the C-terminal region of the precursor.
    DOI:
    10.1080/152165400306214
  • 作为产物:
    参考文献:
    名称:
    Yagupol'skii,L.M.; Malichenko,B.F., Journal of general chemistry of the USSR, 1962, vol. 32, p. 2985 - 2988
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • PROCESS FOR PRODUCING ESTER COMPOUND
    申请人:Imazeki Shigeaki
    公开号:US20100324314A1
    公开(公告)日:2010-12-23
    PROBLEM To provide an environmentally-friendly method for producing industrially an ester compound. SOLUTION The present invention is a method for producing an ester compound which comprises subjecting a carboxylic acid and an alcohol to dehydration-condensation reaction using an involatile acid catalyst and then removing the residual acid catalyst by bringing a weak basic substance into contact with the residual acid catalyst.
    问题提供一种生产工业酯化合物的环保方法。 解决方案是一种生产酯化合物的方法,包括将羧酸和醇经过脱缩合反应,使用一种不挥发的酸催化剂,然后通过将弱碱性物质与残留的酸催化剂接触来去除残留的酸催化剂。
  • 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic
    申请人:Sterling Winthrop, Inc.
    公开号:US05563163A1
    公开(公告)日:1996-10-08
    4-R.sup.4 -R.sup.5 -2-Saccharinylmethyl heterocyclic carboxylates, useful in the treatment of degenerative diseases, are prepared by reacting a 4-R.sup.4 -R.sup.5 -2-halomethylsaccharin with either a heterocyclic carboxylic acid in the presence of an acid-acceptor or the alkali metal salt of a heterocyclic carboxylic acid.
    4-R.sup.4 -R.sup.5 -2-Saccharinylmethyl杂环羧酸酯是治疗退行性疾病的有用化合物,其制备方法为将4-R.sup.4 -R.sup.5 -2-卤代甲基糖精与杂环羧酸在酸接受剂的存在下或杂环羧酸的碱属盐反应。
  • Heterocycle-bearing onium salts
    申请人:Ishihara Masami
    公开号:US20050233253A1
    公开(公告)日:2005-10-20
    The present invention relates to a heterocycle-containing onium salt useful as, for example, a cationic photopolymerization initiator and an acid generator for a chemically amplified resist, and provides “a heterocycle-containing onium salt shown by the general formula [1]: [wherein R is a group shown by the general formula [2]: (wherein R 3 and R 4 are each independently a halogen atom, an alkyl group which may have a halogen atom or an aryl group as a substituent, or an aryl group which may have a halogen atom or a lower alkyl group as a substituent; X 2 is an oxygen atom or a sulfur atom; i is an integer of 0 to 4; and j is an integer of 0 to 3), or a group shown by the general formula [3]: (wherein R 5 and R 6 are each independently a halogen atom, an alkyl group which may have a halogen atom or an aryl group as a substituent, or an aryl group which may have a halogen atom or a lower alkyl group as a substituent; X 3 and X 4 are each independently an oxygen atom or a sulfur atom; p is an integer of 0 to 2; and q is an integer of 0 to 3); R 1 and R 2 are each independently a halogen atom, an alkyl group which may have a halogen atom or an aryl group as a substituent, or an aryl group which may have a halogen atom or a lower alkyl group as a substituent; m and n are each independently an integer of 0 to 5; and A is a halogen atom or an anion derived from an inorganic strong acid, an organic acid or a compound shown by the general formula [4]: HM 1 (R 7 ) 4 [4] (wherein M 1 is a boron atom or a gallium atom; and R 7 is an aryl group which may have a substituent selected from a lower haloalkyl group, a halogen atom, a nitro group and a cyano group)]” or “a heterocycle-containing onium salt shown by the general formula [35]: [wherein R 26 and R 27 are each independently an aryl group which may have a halogen atom or a lower alkyl group as a substituent, a group shown by the above-mentioned general formula [2], or a group shown by the above-mentioned general formula [3]; and A 3 is a halogen atom or an anion derived from an inorganic strong acid, an organic acid or a compound shown by the general formula [4]; and provided that at least one of R 26 and R 27 is a group shown by the above-mentioned general formula [2] or [3], and when only one of R 26 and R 27 is a group shown by the above-mentioned general formula [2] or [3], A 3 is an anion derived from an inorganic strong acid shown by the general formula [36]; HM 3 F 6 [36] (wherein M 3 is a phosphorus atom, an arsenic atom or an antimony atom), an organic acid or a compound shown by the general formula [4]]”.
    本发明涉及一种含杂环离子盐,例如,用作阳离子光聚合引发剂化学增感抗蚀剂的酸发生剂,并提供“一种由通式[1]所示的含杂环离子盐:[其中R是由通式[2]所示的基团:(其中R3和R4分别独立地是卤素原子,可能具有卤素原子或芳基取代基的烷基基团,或可能具有卤素原子或较低烷基基团的芳基基团;X2是氧原子或原子;i是0到4的整数;j是0到3的整数),或由通式[3]所示的基团:(其中R5和R6分别独立地是卤素原子,可能具有卤素原子或芳基取代基的烷基基团,或可能具有卤素原子或较低烷基基团的芳基基团;X3和X4分别独立地是氧原子或原子;p是0到2的整数;q是0到3的整数);R1和R2分别独立地是卤素原子,可能具有卤素原子或芳基取代基的烷基基团,或可能具有卤素原子或较低烷基基团的芳基基团;m和n分别独立地是0到5的整数;A是从无机强酸,有机酸或由通式[4]所示的化合物得到的卤素离子或阴离子:HM1(R7)4[4](其中M1是原子或原子;R7是可能选择自较低卤代烷基基团、卤素原子、硝基基团和基团的芳基基团)]”或“一种由通式[35]所示的含杂环离子盐:[其中R26和R27分别独立地是可能具有卤素原子或较低烷基基团的芳基基团,上述通式[2]所示的基团或上述通式[3]所示的基团;A3是从无机强酸,有机酸或由通式[4]所示的化合物得到的卤素离子或阴离子;并且至少其中之一的R26和R27是上述通式[2]或[3]所示的基团,当仅R26和R27中的一个是上述通式[2]或[3]所示的基团时,A3是从通式[36]所示的无机强酸得到的阴离子:HM3F6[36](其中M3是原子、原子或原子),有机酸或由通式[4]所示的化合物]”。
  • 2-saccharinylmethyl aryl and arloxy acetates useful as proteolytic
    申请人:Sanofi
    公开号:US05783589A1
    公开(公告)日:1998-07-21
    4-R.sup.4 -R.sup.5 -2-Saccharinylmethyl aryl and aryloxy acetates, useful in the treatment of degenerative diseases, are prepared by reacting a 4-R.sup.4 -R.sup.5 -2-halomethylsaccharin with an aryl or aryloxyacetic acid in the presence of an acid-acceptor.
    4-R.sup.4 -R.sup.5 -2-Saccharinylmethyl芳基和芳氧基乙酸酯,可用于治疗退行性疾病,通过在酸受体存在下将4-R.sup.4 -R.sup.5 -2-卤代甲基糖精与芳基或芳氧基乙酸反应制备。
  • Process for preparing 1-octene
    申请人:SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.
    公开号:EP0440995A1
    公开(公告)日:1991-08-14
    This invention relates to a process for producing 1-octenes comprising reacting conjugated dienes and carboxylic acids in the presence of palladium, platinum or ruthenium catalysts to produce 2,7-alkadienyl esters, contacting the 2,7-alkadienyl escers with hydrogen to produce alkyl esters and subsequently pyrolyzing the alkyl esters to produce 1-octene and carboxylic acid.
    本发明涉及一种生产 1-辛烯的工艺,包括在催化剂存在下使共轭二烯和羧酸反应生成 2,7-烷二烯酯,将 2,7-烷二烯擒纵酯与氢接触生成烷基酯,然后将烷基酯热解生成 1-辛烯羧酸
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫